Scaling up API production: How to balance speed with supply chain security

This upcoming webinar from Pharmaron Beijing Co., Ltd. examines the current market demand and trends for the late-phase manufacture and supply of small molecule drug substances.

A range of speakers will be sharing their insights and experience, including:

• James Bruno, a highly regarded CMC consultant, who will provide an outline of market dynamics and the central requirements of clients transitioning into late-phase and commercial small-molecule drug substance production.
• Pharmaron’s Director of Process Chemistry and Manufacture, Dr. Paul Quigley, will be providing an overview of critical scale-up considerations. These involve process scale-up fit for phase, process safety, process analytical technology, velocity, economy, materials science, and technology selection.
• Finally, Pharmaron’s Associate Director of Manufacturing, Chris Harley, will discuss the manufacturing criteria essential for the successful transition to commercial manufacturing. These criteria include process optimization, technical transfer, modeling for scale, green metrics, and equipment selection.

Acknowledgments

Produced from materials originally authored by Pharmaron Beijing Co., Ltd.